Business is booming.

Private equity: the pie is bigger and so are the slices


Barbarians at the gate or pigs at the trough? In a Friday night news dump, KKR announced that its recently named co-chief executives had been granted new shares that could be worth more than $1bn. KKR’s market capitalisation will have to reach $120bn in seven years from $65bn today for the full award to be won.

Both men have worked at KKR for decades and have helped transform it from a small buyout shop to diversified money manager with $459bn in assets. However, they are not the founders who took on personal entrepreneurial risk. Both already have shares worth more than $1bn too. That seems more than enough incentive to raise the company stock price.

KKR and its peers are slowly usurping the traditional banking, insurance and asset management industries. They boast fewer employees and bigger fees.

KKR rival Apollo Global Management is implementing a more radical transformation. Apollo, which is in the midst of merging with its insurance affiliate, will move away from incentive awards paid out from its carried interest “pool” to granting stock in the listed company. Apollo says the move not only puts managers on the same page as shareholders, but vesting requirements ensure talent is persuaded to stay for the long-term.

The firm’s co-presidents, who report to the CEO, have also received stock grants. These are worth more than $300m at Apollo’s current stock price. Unlike the KKR grants, they do not have a premium vesting price. They simply require the two to stay at the firm for several years. A separate, smaller grant requires publicly announced financial targets to be hit. The firms are quick to emphasise that the awards are essentially the only pay that bosses will receive.

In October, Goldman Sachs announced a long-term stock grant for its chief worth potentially $30m. That figure now seems quaint. Then again, Goldman is now smaller, by market cap, than Blackstone, the leading alternative investment manager. Both examples reveal just how much Wall Street’s pecking order has changed.

If you are a subscriber and would like to receive alerts when Lex articles are published, just click the button “Add to myFT”, which appears at the top of this page above the headline.

Source link

  1. Nchioq says

    buy microzide no prescription – order bisoprolol online cheap zebeta price

  2. Kvlxix says

    lopressor for sale – inderal 20mg pills buy nifedipine sale

  3. Aopphe says

    buy nitroglycerin pills – valsartan drug diovan generic

  4. Jgqhgd says

    rosuvastatin online would – caduet buy lie caduet thieve

  5. Ezrtnh says

    simvastatin principal – lipitor natural atorvastatin suspicion

  6. Yzxdcp says

    viagra professional southern – viagra professional online happiness levitra oral jelly growl

  7. Izmpaw says

    dapoxetine study – zudena watcher cialis with dapoxetine practice

  8. Wedxhe says

    cenforce ever – cenforce beer brand viagra pills oh

  9. Mphgxv says

    brand cialis instinct – apcalis dart penisole scatter

  10. Fczvwk says

    cialis soft tabs pills doubt – viagra super active pills wide viagra oral jelly online supper

  11. Jgxomw says

    brand cialis hard – apcalis shall penisole sole

  12. Jjzpjv says

    cialis soft tabs room – cialis oral jelly online smell viagra oral jelly online provide

  13. Xlijkv says

    cenforce enter – tadalafil cost brand viagra draught

  14. Yqfwxj says

    dapoxetine game – fildena intention cialis with dapoxetine paper

  15. Jbgnqr says

    acne medication scar – acne medication which acne medication stain

  16. Aazwix says

    asthma treatment glory – asthma medication hand inhalers for asthma smash

  17. Nzcpui says

    uti antibiotics success – treatment for uti rag treatment for uti female

Leave A Reply

Your email address will not be published.